Skip to the page

Data / Form D filings / ASCALON INTERNATIONAL, INC.

ASCALON INTERNATIONAL, INC.: Form D filings

ASCALON INTERNATIONAL, INC., a pharmaceuticals company in Scottsdale, AZ, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on December 8, 2011, reports $100,000 sold of a $100,000 offering to 2 investors.

Find out what ASCALON INTERNATIONAL, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9977 NORTH 90TH STREET, SUITE 110, Scottsdale, AZ, 85258
Phone
(480) 268-2006
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2009
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506
SEC identifier (CIK)
1489213

The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 8, 2011New notice$100,000$100,000$02Nov 23, 2011sec.gov
May 6, 2010New notice$805,300$805,300$09Apr 21, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Mark LewisExecutive Officer
Eric TookerExecutive Officer, Director
Daniel Von HoffExecutive Officer, Director
Richard LoveDirector
Grant BogleDirector
Edward JacobsExecutive Officer, Director
Jennifer WebsterDirector
Robert SobolExecutive Officer, Director

Every Form D from the week of Dec 5, 2011 · All recent filings in Arizona · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what ASCALON INTERNATIONAL, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.